Prevention of Bleeding

Prevention of Bleeding

Bleeding in patients with cancer results from an interplay of disease- and treatment-related factors. Certain types of cancer such as leukemia have a higher probability of bleeding, with up to 90% of patients with acute promyelocytic leukemia developing hemorrhagic complications. Thrombocytopenia can be caused by chemotherapy or radiation therapy as well as infection, disseminated intravascular coagulation, liver disease, and platelet dysfunction.

ONS PEP resources address only interventions that prevent, reduce, or manage bleeding directly related to cancer and/or its treatment. 

Click here for instructions on navigating the ONS PEP webpages. Have a question about how to apply this PEP topic to your practice? Ask a nurse on ONS staff at clinical@ons.org.

This topic was updated on April 3, 2017. Learn about these updates.

2017 Authors

Nancy Corbitt, BSN, RN, OCN®, CRNI, Joanne Harrington, PhD, ANP-C, AOCNP®, and Trisha Kendall, MS, RN, OCN®

ONS Staff: Margaret M. Irwin, PhD, RN, MN, Christine M. Maloney, BA, Kerri A. Moriarty, MLS, and Mark Vrabel, MLS, AHIP, ELS

 

2007–2016 Authors

Jeannine M. Brant, RN, MS, AOCN®, Nancy Corbitt, BSN, RN, OCN®, CRNI, Barbara I. Damron, PhD, RN, Patricia J. Friend, PhD, RN, AOCN®, Joanne Harrington, PhD, ANP-C, AOCNP®, Trisha Kendall, MS, RN, OCN®, Michele Lacher, RN, OCN®, Michelle Phelan, RN, ACNP-BC, AOCN®, Susan M. Samsonow, RN, OCN®, and Anna D. Schaal, RN, BScN, MS, ARNP

Research Consultant: Sandra Mitchell, CRNP, MScN, AOCN®

ONS Staff: Heather Belansky, RN, MSN, Margaret M. Irwin, PhD, RN, MN, Lee Ann Johnson, PhD, RN, Christine M. Maloney, BA, Kerri A. Moriarty, MLS, Annette Parry Bush, RN, BSN, MBA, OCN®, and Mark Vrabel, MLS, AHIP, ELS

Menu